Vivos Inc (RDGL)

[bdvest]

Be Strong, Great Faith is in something not coming yet but destined to come

Fact No1: The company has made solid progress towards marketing its products isopet and later radiogel, it does have the innovative products which will be generating revenue;

Fact No2: Please do your DD and review RDGL website carefully, it has world class management board and medical consulting board. These people have great education background and managerial experience;

Fact No3: The innovative products isopet had showed effectiveness and minimum side effects in treating dogs and cats cancers, since radiotherapy is still broadly applied treatment option for human cancers, and supposedly there is no species treatment response to radiotherapy, isopet and later radiogel will be highly possible for treating solid tumors in human clinics;

Fact No4: It is true that overall outstanding shares will be doubled, possibly up to 1.4Billion. But how come a company like this only value as 5M. Normally a startup biopharma company only having clinical trials but no products for marketing can still be worthy of tens of or even hundreds of millions.The value of this RDGL was much undervalued, it worth should be at least 100M, therefore considering the oncoming dilution, its should be at least 10 folds of its current market value. This share price of this stock will be more than a dime soon.